Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shuang Yan

Showing results (411-420 of 467) with videos related to

Pageof 47
Sort By:
BMC Psychiatry|April 17, 2025
Association between early childhood outdoor activity and anxiety symptoms in preschoolersJian-Bo Wu, Yan Zhang, Yanni Yang, et al.
Journal of Geriatric Cardiology : JGC|January 24, 2013
Chronic kidney disease: an independent risk factor of all-cause mortality for elderly Chinese patients with chronic heart failureShi-Hui Fu, Bing Zhu, Yu-Xiao Zhang, et al.
Biosensors & Bioelectronics|July 28, 2009
A nano-Ni based ultrasensitive nonenzymatic electrochemical sensor for glucose: enhancing sensitivity through a nanowire array strategyLi-Min Lu, Li Zhang, Feng-Li Qu, et al.
Chemico-Biological Interactions|November 19, 2023
Cyclophosphamide reduces gene transcriptional activity and embryo in vitro development by inhibiting NF-κB expression through decreasing AcH4K12Zhao-Bo Luo, Liu-Hui Yang, Sheng-Zhong Han, et al.
Annals of Hematology|January 12, 2023
Autologous stem cell transplantation in multiple myeloma patients with renal impairmentYingying Zhai, Lingzhi Yan, Song Jin, et al.
The Lancet Regional Health. Western Pacific|July 1, 2024
Efficacy and safety of visepegenatide, a long-acting weekly GLP-1 receptor agonist as monotherapy in type 2 diabetes mellitus: a randomised, double-blind, parallel, placebo-controlled phase 3 trialXiang Yan, Jianhua Ma, Yan Liu, et al.
Scientific Reports|February 1, 2026
Integrating network toxicology, machine learning, and molecular dynamics simulations to reveal tanshinone iia's dual mechanisms in TNBC and doxorubicin-induced cardiotoxicityBo Wu, Xiao-Hong Lan, Xu-Qing Chen, et al.
Molecular Pharmaceutics|April 29, 2026
Novel Covalent FAP-Targeted [<sup>68</sup>Ga]Ga-DOTA-mFS-KERERG-FAP-2286 for Improved Pharmacokinetics and Enhanced Tumor UptakeZhongcai Jin, Tongtong Wu, Shijie Tang, et al.
International Journal of Cardiology|February 19, 2025
A 2D-STI echocardiographic diagnostic model established for cardiac amyloidosis complicated with multiple myelomaHongmiao Shen, Jiali Fan, Xingyue Wu, et al.
Diabetes Research and Clinical Practice|August 27, 2022
Long-term influence of type 2 diabetes and metabolic syndrome on all-cause and cardiovascular death, and microvascular and macrovascular complications in Chinese adults - A 30-year follow-up of the Da Qing diabetes studySiyao He, Jinping Wang, Xiaoxing Zhang, et al.
Pageof 47

Showing results (411-420 of 467) with videos related to

Sort By:
Pageof 47
BMC Psychiatry|April 17, 2025
Association between early childhood outdoor activity and anxiety symptoms in preschoolersJian-Bo Wu, Yan Zhang, Yanni Yang, et al.
Journal of Geriatric Cardiology : JGC|January 24, 2013
Chronic kidney disease: an independent risk factor of all-cause mortality for elderly Chinese patients with chronic heart failureShi-Hui Fu, Bing Zhu, Yu-Xiao Zhang, et al.
Biosensors & Bioelectronics|July 28, 2009
A nano-Ni based ultrasensitive nonenzymatic electrochemical sensor for glucose: enhancing sensitivity through a nanowire array strategyLi-Min Lu, Li Zhang, Feng-Li Qu, et al.
Chemico-Biological Interactions|November 19, 2023
Cyclophosphamide reduces gene transcriptional activity and embryo in vitro development by inhibiting NF-κB expression through decreasing AcH4K12Zhao-Bo Luo, Liu-Hui Yang, Sheng-Zhong Han, et al.
Annals of Hematology|January 12, 2023
Autologous stem cell transplantation in multiple myeloma patients with renal impairmentYingying Zhai, Lingzhi Yan, Song Jin, et al.
The Lancet Regional Health. Western Pacific|July 1, 2024
Efficacy and safety of visepegenatide, a long-acting weekly GLP-1 receptor agonist as monotherapy in type 2 diabetes mellitus: a randomised, double-blind, parallel, placebo-controlled phase 3 trialXiang Yan, Jianhua Ma, Yan Liu, et al.
Scientific Reports|February 1, 2026
Integrating network toxicology, machine learning, and molecular dynamics simulations to reveal tanshinone iia's dual mechanisms in TNBC and doxorubicin-induced cardiotoxicityBo Wu, Xiao-Hong Lan, Xu-Qing Chen, et al.
Molecular Pharmaceutics|April 29, 2026
Novel Covalent FAP-Targeted [<sup>68</sup>Ga]Ga-DOTA-mFS-KERERG-FAP-2286 for Improved Pharmacokinetics and Enhanced Tumor UptakeZhongcai Jin, Tongtong Wu, Shijie Tang, et al.
International Journal of Cardiology|February 19, 2025
A 2D-STI echocardiographic diagnostic model established for cardiac amyloidosis complicated with multiple myelomaHongmiao Shen, Jiali Fan, Xingyue Wu, et al.
Diabetes Research and Clinical Practice|August 27, 2022
Long-term influence of type 2 diabetes and metabolic syndrome on all-cause and cardiovascular death, and microvascular and macrovascular complications in Chinese adults - A 30-year follow-up of the Da Qing diabetes studySiyao He, Jinping Wang, Xiaoxing Zhang, et al.
Pageof 47